Envelhecimento e Diabetes Mellitus Tipo 2: estudo dos efeitos do exercício físico no comportamento postural e capacidade funcional de pacientes com Diabetes Mellitus Tipo 2

A Diabetes Mellitus é uma patologia fortemente associada ao processo de envelhecimento, afectando cada vez mais pessoas em todo o mundo. Uma das maiores complicações observadas nesta população prende-se com a diminuição do controlo postural e da capacidade funcional relacionada com a locomoção. O exercício físico tem sido apontado como uma das formas de prevenção e tratamento deste problema, no entanto existe ainda uma lacuna no conhecimento sobre o modo mais indicado de exercício. O presente pretende avaliar os efeitos de um programa de exercício físico aeróbio sobre o controlo postural e a capacidade funcional de pacientes portadores de Diabetes Mellitus Tipo 2. A amostra do estudo foi composta por 30 sujeitos de ambos os sexos, distribuídos por um grupo experimental (n=16) a quem foi aplicado o programa de exercício físico, e por um grupo de controlo (n=14), o qual não usufruiu de qualquer programa de exercício físico. O programa teve a duração de 12 semanas de treino, e uma frequência de 3 vezes por semana. Os participantes mantiveram-se em movimento constante durante as sessões tendo os exercícios realizados possuído uma forte componente dinâmica. Foi avaliado o controlo postural através de uma plataforma de forças e a capacidade funcional através de um conjunto de cinco testes funcionais. Os resultados obtidos revelam não terem existido diferenças estatisticamente significativas (p>0,05) na interacção entre grupos e momentos de avaliação nas variáveis analisadas, com excepção para a performance no Timed Get Up & Go Test, a qual melhorou significativamente (p<0,05) no grupo experimental. Estes dados sugerem que a especificidade tanto estática como dinâmica dos exercícios e a intensidade a que são realizados são factores fundamentais a ter em consideração no planeamento de programas de exercício físico, com vista à melhoria quer do controlo postural quer da capacidade funcional em portadores de Diabetes Mellius Tipo 2. ABSTRACT: Diabetes Mellitus is a disease associated with aging, affecting a growing number of people all over the world. One of the major concerns in this population relates to the decline of postural control and functional capacity. Exercise has been suggested as one way of preventing and treating this problem, however little is known about the most appropriate mode of exercise. This study evaluates the effect of an aerobic exercise program on postural control and functional capacity of patients with Type 2 Diabetes Mellitus. The sample consisted of 30 subjects, over an experimental group (n = 16) applied to an exercise program, and a control group (n = 14), that received no treatment. The program lasted 12 weeks, three times a week. Participants remained in constant motion during the sessions and the exercises performed had a strong dynamic component. Postural control was assessed using a force platform and functional capacity through a set of five functional tests. The results show that there were no statistically significant differences (p>O, O5) in group/moment interaction in the variables analyzed, except for the Timed Get Up & Go Test, which improved significantly (p <0,05) in the experimental group. These data suggest that both static and dynamic specificity and intensity of exercises are key factors in exercises programs planning, targeted to improve both postural control and functional capacity in patients with Type 2 Diabetes Mellius.

Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes

Metformin is the most commonly used pharmacological therapy for type 2 diabetes. We report a genome-wide association study for glycemic response to metformin in 1,024 Scottish individuals with type 2 diabetes with replication in two cohorts including 1,783 Scottish individuals and 1,113 individuals from the UK Prospective Diabetes Study. In a combined meta-analysis, we identified a SNP, rs11212617, associated with treatment success (n = 3,920, P = 2.9 P×-9, odds ratio = 1.35, 95% CI 1.22-1.49) at a locus containing ATM, the ataxia telangiectasia mutated gene. In a rat hepatoma cell line, inhibition of ATM with KU-55933 attenuated the phosphorylation and activation of AMP-activated protein kinase in response to metformin. We conclude that ATM, a gene known to be involved in DNA repair and cell cycle control, plays a role in the effect of metformin upstream of AMP-activated protein kinase, and variation in this gene alters glycemic response to metformin. © 2011 Nature America, Inc. All rights reserved.

Dose-dependent effects of the once-daily GLP-1 receptor agonist lixisenatide in patients with Type 2 diabetes inadequately controlled with metformin:a randomized, double-blind, placebo-controlled trial

To evaluate the dose-response relationship of lixisenatide (AVE0010), a glucagon-like peptide-1 (GLP-1) receptor agonist, in metformin-treated patients with Type 2 diabetes.

Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus

Glycation, oxidation, and browning of proteins have all been implicated in the development of diabetic complications. We measured the initial Amadori adduct, fructoselysine (FL); two Maillard products, N epsilon-(carboxymethyl) lysine (CML) and pentosidine; and fluorescence (excitation = 328 nm, emission = 378 nm) in skin collagen from 39 type 1 diabetic patients (aged 41.5 +/- 15.3 [17-73] yr; duration of diabetes 17.9 +/- 11.5 [0-46] yr, [mean +/- SD, range]). The measurements were related to the presence of background (n = 9) or proliferative (n = 16) retinopathy; early nephropathy (24-h albumin excretion rate [AER24] &gt; or = 20 micrograms/min; n = 9); and limited joint mobility (LJM; n = 20). FL, CML, pentosidine, and fluorescence increased progressively across diabetic retinopathy (P &lt;0.05, P &lt;0.001, P &lt;0.05, P &lt;0.01, respectively). FL, CML, pentosidine, and fluorescence were also elevated in patients with early nephropathy (P &lt;0.05, P &lt;0.001, P &lt;0.01, P &lt;0.01, respectively). There was no association with LJM. Controlling for age, sex, and duration of diabetes using logistic regression, FL and CML were independently associated with retinopathy (FL odds ratio (OR) = 1.06, 95% confidence interval (CI) = 1.01-1.12, P &lt;0.05; CML OR = 6.77, 95% CI = 1.33-34.56, P &lt;0.05) and with early nephropathy (FL OR = 1.05, 95% CI = 1.01-1.10, P &lt;0.05; CML OR = 13.44, 95% CI = 2.00-93.30, P &lt;0.01). The associations between fluorescence and retinopathy and between pentosidine and nephropathy approached significance (P = 0.05). These data show that FL and Maillard products in skin correlate with functional abnormalities in other tissues and suggest that protein glycation and oxidation (glycoxidation) may be implicated in the development of diabetic retinopathy and early nephropathy.

Predicting the need for insulin therapy in late onset (40-69 years) diabetes mellitus

A six-year prospective study of 144 newly diagnosed, symptomatic diabetic patients aged 40-69 years showed that 21 (15%) required insulin therapy, commencing 1-61 months after diagnosis. The plasma insulin response to oral glucose was assessed at the time of diagnosis. All 12 patients with very low peak insulin response (less than or equal to 6 mU/l) required insulin therapy. Thirty-six patients had an intermediate insulin response (greater than 6 less than or equal to 18 mU/l); of these, 7 with a mean weight 88% (range 73-96%) of average body weight required insulin, while 29 with a mean weight 117% (range 98-158%) of average body weight, did not. Ninety-six patients had a peak insulin response (greater than 18 mU/l); 2 patients whose weights were 96% and 100% of average body weight, required insulin, while the remainder did not. Consideration of initial body weight and peak insulin response provides a useful prediction of the eventual need for insulin.

Increased serum pigment epithelium derived factor levels in Type 2 diabetes patients

Serum PEDF levels (mean (S.D.)) were increased in 96 Type 2 diabetic vs. 54 non-diabetic subjects; 5.3 (2.8) vs. 3.2 (2.0)mug/ml, p

Dipeptidyl peptidase IV and its inhibitors: therapeutics for type 2 diabetes and what else?

The proline-specific dipeptidyl aminopeptidase IV (DPP IV, DPP-4, CD26), widely expressed in mammalians, releases X-Pro/Ala dipeptides from the N-terminus of peptides. DPP IV is responsible of the degradation of the incretin peptide hormones regulating blood glucose levels. Several families of DPP IV inhibitors have been synthesized and evaluated. Their positive effects on the degradation of the incretins and the control of blood glucose levels have been demonstrated in biological models and in clinical trials. Presently, several DPP IV inhibitors, the "gliptins", are approved for type 2 diabetes or are under clinical evaluation. However, the gliptins may also be of therapeutic interest for other diseases beyond the inhibition of incretin degradation. In this Perspective, the biological functions and potential substrates of DPP IV enzymes are reviewed and the characteristics of the DPP IV inhibitors are discussed in view of type 2 diabetes and further therapeutic interest.

Desempeño de las RISS en relación al acceso, coordinación y calidad de la atención en cáncer de mama y diabetes mellitus tipo 2 en Colombia

El objetivo de este capítulo es mostrar los resultados de investigación del desempeño de las redes de servicios de salud frente a diferentes dimensiones relacionadas al acceso, coordinación y calidad de la atención en dos enfermedades crónicas como es el cáncer de mama y la diabetes en Colombia, importantes patologías por su incidencia e impacto así como por la necesidad de la mecanismos efectivos de coordinación para la adecuada atención de los usuarios del sistema de salud. Por tanto, se realiza el análisis del desempeño de dos redes de servicios de salud en la atención de usuarias con diagnostico confirmado de cáncer de mama, vinculadas unas a redes pertenecientes al régimen contributivo y otras al régimen subsidiado. Redes que también fueron consideradas para el análisis del desempeño en la atención de usuarios con diagnostico confirmado de diabetes, en el que de manera adicional participó otra red perteneciente al régimen subsidiado con área de operación en el municipio de Soacha, puesto que las dos anteriores tiene influencia en la ciudad de Bogotá. La fuente primaria de los datos fue la historia clínica y éstos fueron extraídos de acuerdo a ciertos indicadores seleccionados por el equipo investigador a través de un previo proceso de validación y a partir de su importancia para evidenciar el desempeño de las redes de servicios de salud en las dimensiones enunciadas anteriormente. Se muestran los resultados del estudio, a partir de los cuales se propone una breve discusión y conclusiones.

Medication knowledge and self-management by people with type 2 diabetes

<b>Objective: </b>To explore medication knowledge and self management practices of people with type 2 diabetes. <br /><br /><b>Design:</b> A one-shot cross sectional study using in-depth interviews and participant observation. <br /><br /><b>Setting:</b> Diabetes outpatient education centre of a university teaching hospital. <br /><b><br />Subjects:</b> People with type 2 diabetes, n=30, 17 males and 13 females, age range 33-84, from a range of ethnic groups. <br /><br /><b>Outcome measures:</b> Ability to state name, main actions and when to take medicines. Performance of specific medication-related tasks; opening bottles and packs, breaking tablets in half, administering insulin, and testing blood glucose. <br /><br /><b>Results:</b> Average medication use &gt; or = 10 years. Respondents were taking 86 different medicines, mean 7 +/- 2.97 SD. Dose frequency included two, three and four times per day. All respondents had &gt; or = 2 diabetic complications +/- other comorbidities. The majority (93%) were informed about how and when to take their medicines, but only 37% were given information about side effects and 17% were given all possible seven items of information. Younger respondents received more information than older respondents. Older respondents had difficulty opening bottles and breaking tablets in half. Twenty per cent regularly forgot to take their medicines. Increasing medication costs was one reason for stopping medicines or reducing the dose or dose interval. The majority tested their blood glucose but did not control test their meters and 33% placed used sharps directly into the rubbish. <br /><b><br />Conclusion:</b> Polypharmacy was common. Medication knowledge and self management were inadequate and could lead to adverse events.

Further investigation of the psychometric properties of the Insulin Treatment Appraisal Scale among insulin-using and non-insulin-using adults with type 2 diabetes : results from Diabetes MILES-Australia

Negative attitudes towards insulin are commonly reported by people with type 2 diabetes mellitus (T2DM) and can act as a barrier to timely insulin initiation. The Insulin Treatment Appraisal Scale (ITAS) is a widely used 20-item measure of attitudes towards insulin. While designed for completion by both insulin using and non-insulin using adults with T2DM, its psychometric properties have not been investigated separately for these groups. Furthermore, the total score is routinely reported in preference to the published two-factor structure (negative/positive appraisals). Further psychometric validation of the ITAS is required to examine its properties.

Avaliação do efeito do tratamento periodontal não-cirúrgico sobre parâmetros clínicos e imunológicos em pacientes portadores de Diabetes mellitus Tipo 2: estudo clínico e imunológico

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Farmacocinética pré-clínica e avaliação toxicológica preliminar da nova tiazolidinadiona desenvolvida para o tratamento do diabetes mellitus tipo 2: 5-(4-cloro-benzilideno)-3-(4-metil-benzil)-tiazolidina-2,4-diona (GQ-2)

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Avaliação de resultados em um serviço de atenção secundária para pacientes com Diabetes mellitus

OBJETIVO: Avaliar o componente resultado em um serviço de atenção secundária a usuários com Diabetes mellitus tipo 2, tomando como indicadores os controles de pressão arterial, hemoglobina glicada e lipoproteína de baixa densidade. MÉTODOS: Estudo do tipo documental e retrospectivo envolvendo a análise desses indicadores, obtidos nos anos entre 2007 e 2009, com base na consulta de 108 prontuários de usuários de um serviço de atenção secundária, realizada na avaliação de cuidados em saúde. RESULTADOS: Os resultados evidenciaram que 30,3% dos usuários alcançaram a meta para a hemoglobina glicada, 48,1%, para a pressão arterial e 42,3%, para a lipoproteína de baixa densidade. CONCLUSÃO: Os dados avaliados foram semelhantes aos encontrados em outras investigações internacionais e nacionais, com grande proporção de usuários com DM2 estudados, apresentando controle dos níveis hemoglobina A1c, PA e LDL-C, aquém do preconizado nos consensos.